Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) is -84.23% lower on its value in year-to-date trading and has touched a low of $0.53 and a high of $7.11 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IRWD stock was last observed hovering at around $0.63 in the last trading session, with the day’s gains setting it 0.07%.
Currently trading at $0.70, the stock is 10.66% and -5.00% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.73 million and changing 10.12% at the moment leaves the stock -74.04% off its SMA200. IRWD registered -88.01% loss for a year compared to 6-month loss of -80.20%.
The stock witnessed a 14.20% gain in the last 1 month and extending the period to 3 months gives it a -53.10%, and is -3.17% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.61% over the week and 9.86% over the month.
Ironwood Pharmaceuticals Inc (IRWD) has around 253 employees, a market worth around $113.08M and $317.68M in sales. Fwd P/E is 1.97. Profit margin for the company is -9.89%. Distance from 52-week low is 32.57% and -90.16% from its 52-week high. The company has generated returns on investments over the last 12 months (-12.00%).
The EPS is expected to grow by 1644.75% this year
The shares outstanding are 161.81M, and float is at 155.78M with Short Float at 5.28%.
The top institutional shareholder in the company is BLACKROCK INC. with over 22.88 million shares valued at $149.16 million. The investor’s holdings represent 14.3868 of the IRWD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 21.56 million shares valued at $140.59 million to account for 13.5607 of the shares outstanding. The other top investors are SARISSA CAPITAL MANAGEMENT LP which holds 16.39 million shares representing 10.3073 and valued at over $106.86 million, while UBS GROUP AG holds 7.0436 of the shares totaling 11.2 million with a market value of $73.03 million.
Ironwood Pharmaceuticals Inc (IRWD) Insider Activity
The most recent transaction is an insider sale by MCCOURT Thomas A, the company’s Chief Executive Officer. SEC filings show that MCCOURT Thomas A sold 13,353 shares of the company’s common stock on May 16 ’25 at a price of $0.58 per share for a total of $7745.0. Following the sale, the insider now owns 1.15 million shares.
Ironwood Pharmaceuticals Inc disclosed in a document filed with the SEC on May 16 ’25 that Gaskins Tammi L (Chief Commercial Officer) sold a total of 2,563 shares of the company’s common stock. The trade occurred on May 16 ’25 and was made at $0.58 per share for $1487.0. Following the transaction, the insider now directly holds 0.24 million shares of the IRWD stock.
Still, SEC filings show that on May 19 ’25, MCCOURT Thomas A (Officer) Proposed Sale 14,661 shares at an average price of $0.59 for $8650.0. The insider now directly holds shares of Ironwood Pharmaceuticals Inc (IRWD).
